Nucleic acid amplification-based HER2I655V molecular detection for breast cancer
Single Nucleotide Polymorphism at codon 655 of HER2 gene has been extensively evaluated for its role as a susceptible biomarker for breast cancer development and the contradictive result of its role has been a debate among researchers as evidenced from case-control studies. Three platforms of molecu...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Turkiye Klinikleri
2019-04-01
|
Series: | Journal of Oncological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452336418300475 |
_version_ | 1797917357569474560 |
---|---|
author | Bugi Ratno Budiarto Pimpin Utama Pohan Desriani |
author_facet | Bugi Ratno Budiarto Pimpin Utama Pohan Desriani |
author_sort | Bugi Ratno Budiarto |
collection | DOAJ |
description | Single Nucleotide Polymorphism at codon 655 of HER2 gene has been extensively evaluated for its role as a susceptible biomarker for breast cancer development and the contradictive result of its role has been a debate among researchers as evidenced from case-control studies. Three platforms of molecular detection systems named PCR-RFLP, TaqMan assay, and AS-PCR have been used intensively in elucidating this important SNP with considering the affordability and simplicity of detection especially in research format which employs plenty of samples such as in the epidemiological study. Nevertheless, methodological related-bias generated from the association study between HER2I655V SNP and breast cancer risk becomes primary drawback that must be addressed seriously in an attempt to obtain a solid conclusion. This review will discuss the application of nucleic acid amplification-based methods for HER2I655V SNP detection, the potency of bias generated by these genotyping technologies, and strategies to improve their reliability of detection. Keywords: SNP, HER2I655V gene, Breast cancer, Genotyping methods, Genotyping errors |
first_indexed | 2024-04-10T13:12:02Z |
format | Article |
id | doaj.art-ef995670720349088b81bf0cc04efe09 |
institution | Directory Open Access Journal |
issn | 2452-3364 |
language | English |
last_indexed | 2024-04-10T13:12:02Z |
publishDate | 2019-04-01 |
publisher | Turkiye Klinikleri |
record_format | Article |
series | Journal of Oncological Sciences |
spelling | doaj.art-ef995670720349088b81bf0cc04efe092023-02-15T16:12:37ZengTurkiye KlinikleriJournal of Oncological Sciences2452-33642019-04-01513141Nucleic acid amplification-based HER2I655V molecular detection for breast cancerBugi Ratno Budiarto0Pimpin Utama Pohan1 Desriani2Research Center for Biotechnology, Indonesian Institute of Sciences (LIPI), Jalan Raya Bogor Km. 46, Cibinong, 16911, Indonesia; Corresponding author. Research Center for Biotechnology, Indonesian Institute of Sciences-LIPI, Jalan Raya Bogor Km. 46, Cibinong, 16911, Bogor, Jawa Barat, Indonesia. Tel.: +62 021 8754587; fax: +62 021 8754588.Faculty of Medicine, University of North Sumatra, Jalan Dr. T. Mansyur No.5, Padang Bulan, Medan Baru, Kota Medan, Sumatera Utara, IndonesiaResearch Center for Biotechnology, Indonesian Institute of Sciences (LIPI), Jalan Raya Bogor Km. 46, Cibinong, 16911, IndonesiaSingle Nucleotide Polymorphism at codon 655 of HER2 gene has been extensively evaluated for its role as a susceptible biomarker for breast cancer development and the contradictive result of its role has been a debate among researchers as evidenced from case-control studies. Three platforms of molecular detection systems named PCR-RFLP, TaqMan assay, and AS-PCR have been used intensively in elucidating this important SNP with considering the affordability and simplicity of detection especially in research format which employs plenty of samples such as in the epidemiological study. Nevertheless, methodological related-bias generated from the association study between HER2I655V SNP and breast cancer risk becomes primary drawback that must be addressed seriously in an attempt to obtain a solid conclusion. This review will discuss the application of nucleic acid amplification-based methods for HER2I655V SNP detection, the potency of bias generated by these genotyping technologies, and strategies to improve their reliability of detection. Keywords: SNP, HER2I655V gene, Breast cancer, Genotyping methods, Genotyping errorshttp://www.sciencedirect.com/science/article/pii/S2452336418300475 |
spellingShingle | Bugi Ratno Budiarto Pimpin Utama Pohan Desriani Nucleic acid amplification-based HER2I655V molecular detection for breast cancer Journal of Oncological Sciences |
title | Nucleic acid amplification-based HER2I655V molecular detection for breast cancer |
title_full | Nucleic acid amplification-based HER2I655V molecular detection for breast cancer |
title_fullStr | Nucleic acid amplification-based HER2I655V molecular detection for breast cancer |
title_full_unstemmed | Nucleic acid amplification-based HER2I655V molecular detection for breast cancer |
title_short | Nucleic acid amplification-based HER2I655V molecular detection for breast cancer |
title_sort | nucleic acid amplification based her2i655v molecular detection for breast cancer |
url | http://www.sciencedirect.com/science/article/pii/S2452336418300475 |
work_keys_str_mv | AT bugiratnobudiarto nucleicacidamplificationbasedher2i655vmoleculardetectionforbreastcancer AT pimpinutamapohan nucleicacidamplificationbasedher2i655vmoleculardetectionforbreastcancer AT desriani nucleicacidamplificationbasedher2i655vmoleculardetectionforbreastcancer |